Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | RARB | P10826 | 5/20 | 0.62 |
| ▸ | RAB9A | P51151 | 4/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | PLK1 | P53350 | 1/20 | 0.50 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.49 |
| ▸ | ALPL | P05186 | 1/20 | 0.48 |
| ▸ | RARA | P10276 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9483086 | 0.91 | RARB (0.74) | MAPTRARBRAB9AL3MBTL1TDP1 | |
| SCHEMBL7324291 | 0.90 | MAPT (0.66) | MAPTRARBRAB9AL3MBTL1TDP1 | |
| SCHEMBL7314671 | 0.90 | MAPT (0.74) | MAPTRARBRAB9AL3MBTL1TDP1 | |
| SCHEMBL14231641 | 0.90 | MAPT (0.74) | MAPTRARBRAB9AL3MBTL1TDP1 | |
| SCHEMBL6914074 | 0.87 | RARB (0.70) | MAPTRARBRAB9APLA2G4BNPC1 | |
| SCHEMBL7324066 | 0.87 | RARB (0.70) | MAPTRARBRAB9APLA2G4BNPC1 | |
| SCHEMBL9820479 | 0.85 | RARB (0.73) | MAPTRARBRAB9APLA2G4BNPC1 | |
| SCHEMBL7324135 | 0.85 | RARB (0.73) | MAPTRARBRAB9APLA2G4BNPC1 | |
| SCHEMBL13828471 | 0.85 | RARB (0.83) | RARBPLA2G4BRARA | |
| SCHEMBL5352926 | 0.85 | RARB (0.73) | MAPTRARBRAB9APLA2G4BNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8471055-B2 | Photo-crosslinkable liquid crystal monomers with optical activity | CHUNGHWA PICTURE TUBES, LTD. (TW) | 2013-06-25 | — | — | US | disclosed |
| US-20120289731-A1 | PHOTO-CROSSLINKABLE LIQUID CRYSTAL MONOMERS WITH OPTICAL ACTIVITY | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2012-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120289731-A1 | PHOTO-CROSSLINKABLE LIQUID CRYSTAL MONOMERS WITH OPTICAL ACTIVITY | UACA, DLK1, DECR1 | MAPT 300/4885RARB 1613/4885RAB9A 3961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.